Viewing Study NCT03811561


Ignite Creation Date: 2025-12-24 @ 1:10 PM
Ignite Modification Date: 2025-12-28 @ 12:27 AM
Study NCT ID: NCT03811561
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-23
First Post: 2019-01-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module